Remove Programs Remove Reference Remove Treatment
article thumbnail

This app-guided psychedelic treatment works when antidepressants don’t

The Cannigma

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 141
article thumbnail

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals

Puff Puff Post

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.

Programs 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis Advocates to Rally in Kentucky

NORML

It’s vital that we speak as one voice for a medical program.” Patrick Dunegan, Executive Director for Kentucky Cannabis Freedom Coalition (KCFC), “We should not be prisoners of an imaginary border for our health”, referring to Missouri, Ohio, and Illinois becoming emerging medical cannabis markets.

article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025. 310.299.1717 Office.

Programs 100
article thumbnail

MedXtractor Fills a Key Gap in Mental Health Treatments

Cannabis Law Report

s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

article thumbnail

The STATES Act Reintroduced: Bipartisan Measure Limits Federal Government’s Ability To Interfere With State-Sanctioned Marijuana Business, Policies

NORML

Our outdated laws have ruined lives, devastated communities, and wasted resources for critical medical treatment and research. HR 1455 : The REFER Act (Restraining Excessive Federal Enforcement & Regulations of Cannabis Act), introduced by Congresswoman Barbara Lee (D-CA). ” Said Rep. .”

Policy 185
article thumbnail

Medical Marijuana to Treat Glaucoma: What You Need To Know

MMJ Recs

Traditional treatments include eye drops, oral medications, laser treatment, and surgery. This article explores the potential of medical marijuana for glaucoma treatment, focusing on its benefits, risks, and legal considerations. Several studies have shown that cannabinoids, the active compounds in marijuana, can lower IOP.

Treatment 111